UPDATE : Friday, June 5, 2020
상단여백
Meditoxin’s future uncertain, even as final verdict nears
A recent series of development over Medytox’s botulinum toxin is making it ...
by Jeong Sae-im  |  2020-05-25 14:38
라인
Fall in new Covid-19 cases hampers developing treatment
Local drug companies are making an all-out effort to increase sites for cli...
by Jeong Sae-im  |  2020-05-22 17:31
라인
Korean pharma’s Q1 performance not affected by Covid-19
Despite the global spread of the new coronavirus, the local pharmaceutical ...
by Kim Yun-mi  |  2020-05-22 17:29
라인
Chinese regulator OKs Genexine's P2 trial of glioblastoma treatment
Genexine said that China's National Medical Products Administration has...
by Lee Han-soo  |  2020-05-22 17:23
라인
JW Pharma launches long-lasting hydraulic acid filler
JW Pharmaceutical said that it has launched Hyalanse, a long-lasting hyalur...
by Lee Han-soo  |  2020-05-22 16:20
라인
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’  
An infectious disease expert cautioned against the hasty interpretation of ...
by Kim Yun-mi  |  2020-05-22 15:27
라인
Alvogen’s obesity drug threatens Novo Nordisk's stronghold in Korea
Novo Nordisk’s Saxenda is facing fierce competition to keep its dominance i...
by Lee Han-soo  |  2020-05-22 15:19
라인
Alvogen Korea to market Luye Pharma’s schizophrenia treatment
Alvogen Korea said that it would exclusively supply and market Luye Pharma ...
by Lee Han-soo  |  2020-05-21 17:02
라인
[Exclusive] Thailand recalls Medytox’s botulinum toxin
The Thai government not only suspended the sale of Meditoxin, a botulinum t...
by Jeong Sae-im  |  2020-05-21 12:33
라인
SK’s offshoot picked as major raw material supplier to US
SK Holdings said Wednesday its active drug ingredient maker, AMPAC Fine Che...
by Shim Hyun-tai  |  2020-05-20 18:32
라인
Eisai Korea expands indication for epilepsy treatment
Eisai Korea said that it has received an expanded indication for Fycompa, a...
by Lee Han-soo  |  2020-05-20 17:11
라인
Hungary OKs Aptabio's P2 trial for diabetic nephropathy treatment
Aptabio said that the Hungarian health authorities have approved its invest...
by Lee Han-soo  |  2020-05-20 15:41
라인
Drugmakers brief development progress of Covid-19 treatments at ‘Bio Korea 2020’
Biopharmaceutical companies introduced their development progress of Covid-...
by Shim Hyun-tai  |  2020-05-19 17:54
라인
ISU Abxis releases preclinical trial results for anticancer antibody
ISU Abxis has presented the preclinical trial results for ISU104, an anti-E...
by Lee Han-soo  |  2020-05-18 15:19
라인
SK Bioscience gets Gates Foundation's fund to develop Covid-19 vaccine
SK Bioscience said it has won the Bill & Melinda Gates Foundation's res...
by Lee Han-soo  |  2020-05-18 14:53
라인
GC Pharma to supply Covid-19 treatment for free
GC Pharma said that it would provide GC5131A, the world's first plasma ...
by Lee Han-soo  |  2020-05-18 11:36
라인
Medytox’s earnings plummet amid lawsuit against Daewoong
Medytox, the nation’s largest botulinum toxin maker by market share, suffer...
by Jeong Sae-im  |  2020-05-18 11:33
라인
‘Many shareholders suffered from Medytox’s public notice of false information’
OhKims Law and Company is recruiting investors for its second suit against ...
by Shim Hyun-tai  |  2020-05-15 17:40
라인
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
Hanmi Pharmaceutical’s diabetes drug candidate efpeglenatide, which had led...
by Jeong Sae-im  |  2020-05-15 13:14
라인
‘Lynparza extended survival of ovarian cancer patients’
AstraZeneca said Lynparza (ingredient: olaparib) has become the first poly ...
by Kim Yun-mi  |  2020-05-14 15:14
여백
여백
여백
Back to Top